Digital mammography breast density estimates compared with standard-dose mammography.
Automated estimates of breast density made from synthetic digital mammograms is comparable to those from standard-dose mammograms, according to a study published in Radiology.
Researchers from the University of Pennsylvania in Philadelphia undertook a study to evaluate agreement between automated estimates of breast density made from standard-dose versus synthetic digital mammograms in a large cohort of women undergoing screening.
The study included 3,668 negative (Breast Imaging Reporting and Data System category 1 or 2) digital breast tomosynthesis (DBT) screening examinations consecutively performed over a four-month period. Both standard-dose and synthetic mammograms were available for analysis and were retrospectively analyzed.
The “For Presentation” standard-dose mammograms and synthetic images were analyzed by using a fully automated algorithm. Agreement between density estimates was assessed by using Pearson correlation, linear regression, and Bland-Altman analysis. Differences were evaluated by using the paired Student t test.
The results showed that breast percentage density (PD) estimates from synthetic and standard-dose mammograms were highly correlated (r = 0.92, P < .001), and the 95% Bland-Altman limits of agreement between PD estimates were −6.4% to 9.9%. The synthetic mammograms had PD estimates an average of 1.7% higher than standard-dose mammograms), with a larger disagreement by 1.56% in women with highly dense breast tissue.
The researchers concluded that fully automated estimates of breast density made from synthetic mammograms were generally comparable to those made from standard-dose mammograms. This finding could be important, they wrote. As clinicians strive to reduce radiation doses in screening mammograms, standard two-dimensional mammographic images are increasingly being replaced by synthetic mammograms in DBT screening.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.